AUTOLOGOUS NEUTRALIZING ANTIBODIES PREVAIL IN HIV-2 BUT NOT IN HIV-1 INFECTION

被引:74
作者
BJORLING, E
SCARLATTI, G
VONGEGERFELT, A
ALBERT, J
BIBERFELD, G
CHIODI, F
NORRBY, E
FENYO, EM
机构
[1] KAROLINSKA INST, DEPT VIROL, S-10521 STOCKHOLM, SWEDEN
[2] NATL BACTERIOL LAB, DEPT VIROL, S-10521 STOCKHOLM, SWEDEN
[3] NATL BACTERIOL LAB, DEPT IMMUNOL, S-10521 STOCKHOLM, SWEDEN
关键词
D O I
10.1006/viro.1993.1160
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 2 (HIV-2) has been reported to be less pathogenic than HIV-1. We have investigated the capacity of sera from nine HIV-2-infected individuals to neutralize their own autologous virus. All nine HIV-2-infected individuals neutralized autologous virus with titers ranging between 20 and 320. In contrast, we have previously reported that most HIV-1-infected individuals lack such antibodies. The difference between HIV-1 and HIV-2 infection was statistically significant (P < 0.0002, Pearson test) and the difference in neutralizing antibody prevalence may explain the faster disease progression in HIV-1-infected individuals than in HIV-2-infected individuals. © 1993 Academic Press, Inc.
引用
收藏
页码:528 / 530
页数:3
相关论文
共 22 条
[1]   RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA [J].
ALBERT, J ;
ABRAHAMSSON, B ;
NAGY, K ;
AURELIUS, E ;
GAINES, H ;
NYSTROM, G ;
FENYO, EM .
AIDS, 1990, 4 (02) :107-112
[2]   REPLICATIVE CAPACITY OF HIV-2, LIKE HIV-1, CORRELATES WITH SEVERITY OF IMMUNODEFICIENCY [J].
ALBERT, J ;
NAUCLER, A ;
BOTTIGER, B ;
BROLIDEN, PA ;
ALBINO, P ;
OUATTARA, SA ;
BJORKEGREN, C ;
VALENTIN, A ;
BIBERFELD, G ;
FENYO, EM .
AIDS, 1990, 4 (04) :291-295
[3]  
ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303
[4]  
ASJO B, 1986, LANCET, V2, P660
[5]   INVIVO GENETIC-VARIABILITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 V3-REGION [J].
BOERI, E ;
GIRI, A ;
LILLO, F ;
FERRARI, G ;
VARNIER, OE ;
FERRO, A ;
SABBATANI, S ;
SAXINGER, WC ;
FRANCHINI, G .
JOURNAL OF VIROLOGY, 1992, 66 (07) :4546-4550
[6]  
BOLOGNESI DP, 1988, MICROBIOL SCI, V5, P236
[7]  
BOTTIGER B, 1990, J VIROL, V64, P3492
[8]   A COMPARISON OF HIV-1 AND HIV-2 INFECTIONS IN HOSPITALIZED-PATIENTS IN ABIDJAN, IVORY-COAST [J].
DECOCK, KM ;
ODEHOURI, K ;
COLEBUNDERS, RL ;
ADJORLOLO, G ;
LAFONTAINE, MF ;
PORTER, A ;
GNAORE, E ;
DIABY, L ;
MOREAU, J ;
HEYWARD, WL .
AIDS, 1990, 4 (05) :443-448
[9]   ANTIBODY-MEDIATED INVITRO NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ABOLISHES INFECTIVITY FOR CHIMPANZEES [J].
EMINI, EA ;
NARA, PL ;
SCHLEIF, WA ;
LEWIS, JA ;
DAVIDE, JP ;
LEE, DR ;
KESSLER, J ;
CONLEY, S ;
MATSUSHITA, S ;
PUTNEY, SD ;
GERETY, RJ ;
EICHBERG, JW .
JOURNAL OF VIROLOGY, 1990, 64 (08) :3674-3678
[10]   HUMAN INFECTION BY GENETICALLY DIVERSE SIVSM-RELATED HIV-2 IN WEST AFRICA [J].
GAO, F ;
YUE, L ;
WHITE, AT ;
PAPPAS, PG ;
BARCHUE, J ;
HANSON, AP ;
GREENE, BM ;
SHARP, PM ;
SHAW, GM ;
HAHN, BH .
NATURE, 1992, 358 (6386) :495-499